Homocysteine and markers of coagulation and endothelial cell activation von Gerdes, V. E. A., Hovinga, H. A. Kremer, Ten Cate, H., Macgillavry, M. R., Leijte, A., Reitsma, P. H., Brandjes, D. P. M., Büller, H. R.

Volltext

Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study von DOUKETIS, J. D., JULIAN, J. A., KEARON, C., ANDERSON, D. R., CROWTHER, M. A., BATES, S. M., BARONE, M., PIOVELLA, F., TURPIE, A. G., MIDDELDORP, S., VAN NGUYEN, P., PRANDONI, P., WELLS, P. S., KOVACS, M. J., MACGILLAVRY, M. R., COSTANTINI, L., GINSBERG, J. S.

Volltext

Non‐invasive diagnostic work‐up of patients with clinically suspected pulmonary embolism; results of a management study von Ten Wolde, M., Hagen, P. J., Macgillavry, M. R., Pollen, I. J., Mairuhu, A. T. A., Koopman, M. M. W., Prins, M. H., Hoekstra, O. S., Brandjes, D. P. M., Postmus, P. E., Büller, H. R.

Volltext

Left superior vena cava, a remnant of embryological development von Sondermeijer, B. M., MacGillavry, M. R., Tan, H. L.

Volltext

Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism von ten Wolde, M., Söhne, M., Quak, E., MacGillavry, M.R., Büller, H.R.

Volltext

Low adjusted‐dose acenocoumarol therapy in sickle cell disease: A pilot study von Schnog, J.B., Kater, A.P., Mac Gillavry, M.R., Duits, A.J., Lard, L.R., van der Dijs, F.P.L., Brandjes, D.P.M., ten Cate, H., Statius van Eps, L.W., Rojer, R.A.

Volltext

No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease von Schnog, J.B., Mac Gillavry, M.R., Rojer, R.A., Meijers, J.C.M., Fijnheer, R., ten Cate, H., Brandjes, D.P.M., Duits, A.J.

Volltext